Cite
HARVARD Citation
Raval, A. et al. (2021). Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort. International journal of cardiology. pp. 131-138. [Online].